1. Home
  2. FGI vs HIND Comparison

FGI vs HIND Comparison

Compare FGI & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FGI

FGI Industries Ltd.

N/A

Current Price

$7.78

Market Cap

14.5M

Sector

Industrials

ML Signal

N/A

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

N/A

Current Price

$1.77

Market Cap

15.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FGI
HIND
Founded
1987
2017
Country
United States
United States
Employees
N/A
2
Industry
Industrial Specialties
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
15.2M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
FGI
HIND
Price
$7.78
$1.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
★ $10.00
$8.83
AVG Volume (30 Days)
★ 8.6K
8.5K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 64.86
EPS
★ 0.17
N/A
Revenue
N/A
★ $319,714.00
Revenue This Year
$3.45
N/A
Revenue Next Year
$5.39
$82.65
P/E Ratio
$49.53
★ N/A
Revenue Growth
N/A
★ 24.43
52 Week Low
$3.14
$1.62
52 Week High
$19.93
$6.56

Technical Indicators

Market Signals
Indicator
FGI
HIND
Relative Strength Index (RSI) 52.81 50.47
Support Level $6.64 $1.82
Resistance Level $8.23 $2.31
Average True Range (ATR) 0.59 0.10
MACD 0.07 -0.00
Stochastic Oscillator 54.48 53.17

Price Performance

Historical Comparison
FGI
HIND

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, it generates the majority of its revenue from the United States, followed by Canada and Europe.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: